# Lopinavir/r Monotherapy Versus Abacavir/Lamivudine and Lopinavir/r for Limb Fat Recovery in Persons With Lipoatrophy

> **NCT00865007** · PHASE4 · COMPLETED · sponsor: **Fundacion SEIMC-GESIDA** · enrollment: 88 (actual)

## Conditions studied

- HIV Infection
- Lipodystrophy
- HIV Infections

## Interventions

- **DRUG:** Monotherapy (Lopinavir/ritonavir)
- **DRUG:** Monotherapy (Lopinavir/ritonavir) + ABC/3TC

## Key facts

- **NCT ID:** NCT00865007
- **Lead sponsor:** Fundacion SEIMC-GESIDA
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2012-06
- **Final completion:** 2012-09
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2013-03-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00865007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00865007, "Lopinavir/r Monotherapy Versus Abacavir/Lamivudine and Lopinavir/r for Limb Fat Recovery in Persons With Lipoatrophy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00865007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*